4 Reasons to Avoid the GoodRx IPO

Initial public offerings from consumer-focused digital healthcare platforms have been terrific sources of gains for investors in 2020, and there's another big one on the way. Shares of GoodRx (NASDAQ:GDRX) are expected to begin trading soon, and plenty of everyday investors find the company's prospectus compelling.

Digital coupons that route sales of prescription drugs through a pharmacy benefit manager (PBM) are increasingly popular. GoodRx -- a price comparison app that offers such coupons -- stands to benefit from that rise. Before you dive in, though, there are a few things you should know.

Image source: Getty Images.

Continue reading

Source Fool.com